Ashland (NYSE:ASH – Get Rating) had its price target cut by stock analysts at Wells Fargo & Company  from $115.00 to $110.00 in a note issued to investors on Monday, Benzinga reports. The brokerage currently has an “equal weight” rating on the basic materials company’s stock. Wells Fargo & Company‘s price objective suggests a potential upside of 6.01% from the company’s current price.

Other analysts have also issued research reports about the stock. StockNews.com assumed coverage on shares of Ashland in a research note on Thursday, March 16th. They set a “hold” rating on the stock. BMO Capital Markets lifted their price objective on shares of Ashland from $135.00 to $136.00 and gave the stock an “outperform” rating in a report on Thursday, February 2nd. UBS Group lifted their price objective on shares of Ashland from $131.00 to $135.00 and gave the stock a “buy” rating in a report on Wednesday, January 11th. Mizuho decreased their price objective on shares of Ashland from $141.00 to $136.00 and set a “buy” rating for the company in a report on Thursday, January 26th. Finally, JPMorgan Chase & Co. downgraded shares of Ashland from a “neutral” rating to an “underweight” rating and lifted their price objective for the stock from $104.00 to $105.00 in a report on Thursday, February 2nd. One analyst  has rated the stock with a sell rating, two have given a hold rating and four have issued  a buy rating to the stock. Based on data from MarketBeat, the company  has an average rating of “Hold” and an average target price of $127.50.

NYSE ASH opened at $103.76 on Monday. Ashland has a one year low of $91.66 and a one year high of $114.36. The company’s 50 day moving average price is $101.29 and its 200 day moving average price is $104.59. The company has a debt-to-equity ratio of 0.40, a quick ratio of 2.16 and a current ratio of 3.72. The firm has a market capitalization of $5.63 billion, a price-to-earnings ratio of 6.44 and a beta of 1.00.

Ashland (NYSE:ASH – Get Rating) last posted its quarterly earnings results on Wednesday, February 1st. The basic materials company reported $0.97 EPS for the quarter, beating the consensus estimate of $0.95 by $0.02. Ashland had a net margin of 38.23% and a return on equity of 9.82%. The firm had revenue of $525.00 million for the quarter, compared to analyst estimates of $516.58 million. During the same quarter last year, the firm posted $0.88 earnings per share. Ashland’s revenue for the quarter was up 2.5% compared to the same quarter last year.  On average, sell-side analysts predict that  Ashland will post 6.32 EPS for the current year.

Hedge funds and other institutional investors have recently bought and sold shares of the business. Cubist Systematic Strategies LLC raised its position in  Ashland by 34.1% in the third quarter. Cubist Systematic Strategies LLC now owns 46,808 shares of the basic materials company’s stock worth $4,445,000 after acquiring an additional 11,906 shares in the last quarter.  Renaissance Technologies LLC bought a new stake in  Ashland in the third quarter worth about $9,523,000.  Teacher Retirement System of Texas raised its position in  Ashland by 115.0% in the third quarter. Teacher Retirement System of Texas now owns 18,697 shares of the basic materials company’s stock worth $1,776,000 after acquiring an additional 9,999 shares in the last quarter.  Advisors Asset Management Inc. increased its stake in  Ashland by 10.6% in the 3rd quarter. Advisors Asset Management Inc. now owns 7,487 shares of the basic materials company’s stock worth $711,000 after purchasing an additional 717 shares in the last quarter.  Finally, Cerro Pacific Wealth Advisors LLC increased its stake in  Ashland by 6.7% in the 4th quarter. Cerro Pacific Wealth Advisors LLC now owns 2,582 shares of the basic materials company’s stock worth $278,000 after purchasing an additional 163 shares in the last quarter. 92.21% of the stock is currently owned by institutional investors.

Ashland, Inc engages in the provision of architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical. It operates through the following segments: Life Sciences, Personal Care, Special Additives, and Intermediates. The company was founded in 1924 and is headquartered in Wilmington, DE.

Receive News & Ratings for Ashland Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ashland and related companies with MarketBeat.com's FREE daily email newsletter.